← Evidence map

ArticleCell death & disease2026

Inhibition of autoantigen-induced B-cell receptor (BCR) internalization as a therapeutic strategy in diffuse large B cell lymphoma (DLBCL).

Patryk Górniak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Inhibition of autoantigen-induced B-cell receptor (BCR) internalization as a therapeutic strategy in diffuse large B cell lymphoma (DLBCL). | OpenQuestion